Literature DB >> 10445791

The effect of eradicating Helicobacter pylori infection on the course of adenomatous and hyperplastic gastric polyps.

N Ljubicić1, M Banić, M Kujundzić, Z Antić, M Vrkljan, I Kovacević, D Hrabar, M Doko, M Zovak, S Mihatov.   

Abstract

OBJECTIVE: Histopathological and clinical data strongly suggest that Helicobacter pylori is the cause of chronic gastritis and peptic ulceration. However, little has been written about the potential causal relation of H. pylori infection to hyperplastic and adenomatous gastric polyps. We therefore carried out a prospective study to determine the effect of eradicating H. pylori infection on the course of hyperplastic and adenomatous gastric polyps.
METHODS: From November 1996 to December 1997, 6700 patients who had undergone upper gastrointestinal endoscopy at the two centres in Zagreb, Croatia, were candidates for participation in the study. Hyperplastic and adenomatous polyps were diagnosed on a basis of at least three histological samples taken from the polyp. In seven patients endoscopy had to be repeated because forceps biopsy sampling either provided inadequate tissue for correct histological diagnosis, or accurate characterization of gastric polyp histology was not possible. Upon completion of all endoscopic examinations before and after treatment, biopsy samples were taken from the antrum (two) and the body of the stomach (two) so that gastritis could be graded and classified, and the presence of H. pylori sought by histology. Two other samples were taken from the antrum for a rapid urease test. Follow-up examinations were performed by using endoscopy. Control endoscopy was performed at least 4 weeks after the treatment of H. pylori infection had been completed, and then every 3-4 months. The follow-up ranged from 4 to 17 months, with a median of 14 months. The treatment of H. pylori infection consisted of a 1-week course of either omeprazole (20 mg twice daily) or pantoprazole 40 mg twice daily), and a 1-week course of amoxicillin 2g twice daily) and metronidazole (400 mg three times daily), and clarithromycin (500 mg twice daily). Eradication of H. pylori infection was assessed by repeated histology and rapid urease test.
RESULTS: Twenty-one patients (nine women, 12 men; median age 52 years) with histologically proven hyperplastic gastric polyps, and seven patients (two women, five men; median age, 67 years) with adenomatous gastric polyps were included in the study. Among 21 patients with hyperplastic gastric polyps, 16 patients (76%) were positive for H. pylori infection. Only two patients (29%) with adenomatous gastric polyps were positive for the infection. Complete eradication of H. pylori was initially achieved in all patients positive for H. pylori. Total regression of the gastric polyps was observed only among the patients with hyperplastic gastric polyps in whom H. pylori had been eradicated. Complete regression of the hyperplastic gastric polyps was observed in seven of the 16 evaluable patients (44%; 95% CI, 19-68%) after H. pylori eradication. The endoscopic snare polypectomy was carried out in nine patients with hyperplastic polyps and two patients with adenomatous gastric polyps in whom regression of the polyps was not observed after H. pylori eradication, as well as in five patients with hyperplastic and four with adenomatous gastric polyps who were negative for H. pylori. Exploratory laparotomy and gastrotomy with polyps excision were carried out in one patient with multiple adenomatous gastric polyps. In only one patient who was not positive for H. pylori recurrence of hyperplastic gastric polyp was recorded during follow-up, and no re-infection with H. pylori has been detected.
CONCLUSIONS: Our results suggest that the development of hyperplastic gastric polyps may be directly related to chronic active gastritis and concomitant H. pylori infection. Cure of H. pylori infection associated with hyperplastic gastric polyps resulted in complete polyp regression in more than 40% of patients. Therefore, for patients with hyperplastic gastric polyps and concurrent H. pylori infection an antibiotic treatment designed to eradicate H. pylori appears to be recommended before further therapeutic options are consi

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10445791     DOI: 10.1097/00042737-199907000-00008

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  20 in total

1.  Histologic characteristics of gastric polyps in Korea: emphasis on discrepancy between endoscopic forceps biopsy and endoscopic mucosal resection specimen.

Authors:  Won Jae Yoon; Dong Ho Lee; Yong Jin Jung; Ji Bong Jeong; Ji Won Kim; Byeong Gwan Kim; Kook Lae Lee; Kwang Hyuck Lee; Young Soo Park; Jin-Hyeok Hwang; Jin-Wook Kim; Nayoung Kim; Jun Kyu Lee; Hyun Chae Jung; Yong Bum Yoon; In Sung Song
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

2.  Gastric polyps: a review of clinical, endoscopic, and histopathologic features and management decisions.

Authors:  Rafiul Sameer Islam; Neal C Patel; Dora Lam-Himlin; Cuong C Nguyen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-10

3.  Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa?

Authors:  Klaus Dirschmid; Claudia Platz-Baudin; Manfred Stolte
Journal:  Virchows Arch       Date:  2005-09-28       Impact factor: 4.064

4.  Effect of Helicobacter pylori eradication on gastric hyperplastic polyposis in Cowden's disease.

Authors:  Hajime Isomoto; Hisashi Furusu; Ken Ohnita; Yusuke Takehara; Chun-Yang Wen; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

5.  Intermittent gastric outlet obstruction caused by a prolapsing antral gastric polyp.

Authors:  Mehul Parikh; Brian Kelley; Gabriel Rendon; Bincy Abraham
Journal:  World J Gastrointest Oncol       Date:  2010-05-15

6.  Gastric inflammatory fibroid polyp morphologically changed by Helicobacter pylori eradication.

Authors:  Yasuhiro Mitsui; Kaizo Kagemoto; Tatsuzo Itagaki; Shuji Inoue; Keishi Naruse; Naoki Muguruma; Tetsuji Takayama
Journal:  Clin J Gastroenterol       Date:  2015-03-03

Review 7.  Helicobacter pylori interactions with host serum and extracellular matrix proteins: potential role in the infectious process.

Authors:  J Daniel Dubreuil; Giuseppe Del Giudice; Rino Rappuoli
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

8.  Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial.

Authors:  Feng Ji; Zi-Wei Wang; Jian-Wen Ning; Qun-Yan Wang; Jian-Yong Chen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

Review 9.  Management of gastric polyps: a pathology-based guide for gastroenterologists.

Authors:  Susanne W Carmack; Robert M Genta; David Y Graham; Gregory Y Lauwers
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-06       Impact factor: 46.802

10.  Changes in the spectrum of gastric polyps in the Chinese population.

Authors:  Nan-Nan Fan; Jing Yang; Gang Sun; Zhong-Sheng Lu; En-Qiang Ling Hu; Xiang-Dong Wang; Yun-Sheng Yang
Journal:  World J Gastroenterol       Date:  2015-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.